Stella Wong

Preparing for global patent litigation for a biotechnology company in relation to its blockbuster antibody and supervising and coordinating parallel preparations in multiple European jurisdictions. 

Preparing for global patent litigation in relation to an immuno-oncology drug and coordinating parallel preparations in European jurisdictions.

Acting in its multi-jurisdictional patent litigation in relation to coronary stents.

Acting in European Patent Office opposition proceedings in relation to hydrophilic coated urinary catheters.

Acting for Merck, Sharp & Dohme Limited in obtaining the first ever zero term supplementary protection certificate for a pharmaceutical product.

Acting for Merck, Sharp & Dohme Limited in relation to its patent and patent application for Alendronate, a drug used in the treatment of osteoporosis.

Acting for AGA Medical Corporation in UK patent litigation against Occlutech (UK) limited concerning medical device; parallel litigation in other jurisdictions and European Patent Office.

Acting for Eli Lilly and Company in UK patent litigation proceedings against Actavis concerning a cancer drug.

Acting in a US, UK and Dutch patent litigation involving LED technology.

Acting in a multi-jurisdictional patent litigation involving mobile phone technology.

Advising on patent issues relating to a digital farming application.

Acting in a UK patent litigation relating to a non-invasive prenatal test.

Advising in a global patent litigation strategy in relation to patents for medical imaging.

Acting in multijurisdictional patent litgation in relation to patents for wind turbines.

Acting in multijurisdictional patent litigation in relation to a rare earth oxide catalyst patent for the liability and damages first instance trials and on their appeals.

Acting at first instance and on appeal in patent litigation relating to patents for the treatment of anaemias.